HOME › DRUGS › SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE

Brand name(s): SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA217395
ACTIVE SUBSTANCE
Sitagliptin Phosphate Anhydrous, Metformin Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
MSN LABORATORIES PRIVATE LTD
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA217395MSN LABORATORIES PRIVATE LTDNone (Tentative Approval)

FULL INTELLIGENCE ON SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →